Production (Stage)
Avenue Therapeutics, Inc.
ATXI
$0.2088
-$0.0113-5.13%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.50M | 2.59M | 2.60M | 4.92M | 3.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 92.00K | 78.00K | 28.00K | 69.00K | 116.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.59M | 2.67M | 2.63M | 4.99M | 3.31M |
|
|
|||||
| Total Current Assets | 3.59M | 2.67M | 2.63M | 4.99M | 3.31M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.59M | 2.67M | 2.63M | 4.99M | 3.31M |
|
|
|||||
| Total Accounts Payable | 431.00K | 301.00K | 657.00K | 592.00K | 662.00K |
| Total Accrued Expenses | 830.00K | 499.00K | 287.00K | 522.00K | 337.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.00K | 16.00K | 29.00K | 47.00K | 413.00K |
| Total Other Current Liabilities | 1.00K | 16.00K | 29.00K | 47.00K | 413.00K |
| Total Current Liabilities | 1.26M | 816.00K | 973.00K | 1.16M | 1.41M |
|
|
|||||
| Total Current Liabilities | 1.26M | 816.00K | 973.00K | 1.16M | 1.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.26M | 816.00K | 973.00K | 1.16M | 1.41M |
|
|
|||||
| Common Stock & APIC | 107.94M | 105.38M | 103.65M | 102.72M | 98.10M |
| Retained Earnings | -104.43M | -102.58M | -101.04M | -97.96M | -95.27M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.51M | 2.80M | 2.61M | 4.76M | 2.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.51M | 2.80M | 2.61M | 4.76M | 2.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.18M | -941.00K | -958.00K | -937.00K | -938.00K |
| Total Equity | 2.33M | 1.86M | 1.65M | 3.83M | 1.90M |
|
|
|||||